Lumida
/BBNX
⌘K
Beta Bionics Inc

Beta Bionics Inc

BBNX
$17.29USD+2.31%+0.39 today

MARKET CAP

770.5M

P/E (TTM)

FWD P/E

DAY RANGE

$16 – $18

52W RANGE

$9
$33

AI Summary

Stalk
StalkMedium

BBNX remains in a Stage 2 advancing regime with clear higher highs and higher lows supported by rising EMAs. Price is extended into overbought territory near prior resistance and shows minor exhaustion signals, making short-term timing unfavorable. We defer entries and look for a selective pullback into the rising 9/21 EMA support zone. A decisive close below the 21 EMA on increased volume would invalidate the medium-term bullish bias and require reassessment.

  • Q1 net sales reached $27.6M, up 57% YoY, driving revenue momentum.
  • Gross margin expanded to 59.5%, up ~400bps YoY via high-margin pharmacy channel.
  • Operating expenses rose to $40.7M, a 47% YoY increase, pressuring cash burn.
Full analysis →
Insider Trades42 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 26, 2026SellBBNXStephen FeiderChief Financial Officer19,878$11.11$770.5M-47.14%+96.48%$220.8K-0.02%10b5-1Stalk
Jun 26, 2026SellBBNXStephen FeiderChief Financial Officer20,000$11.07$770.5M-47.14%+96.48%$221.4K+0.00%10b5-1Stalk
Jun 24, 2026SellBBNXMark HopmanChief Commercial Officer1,258$15.01$770.5M-47.14%+96.48%$18.9K-0.96%10b5-1Stalk
Jun 4, 2026SellBBNXMark HopmanChief Commercial Officer275$12.31$770.5M-47.14%+96.48%$3.4K-0.21%10b5-1Stalk
Jun 2, 2026SellBBNXSteven Jon RussellChief Medical Officer4,222$12.61$770.5M-47.14%+96.48%$53.2K-2.37%Stalk
Jun 2, 2026SellBBNXMike MensingerChief Product Officer4,378$12.61$770.5M-47.14%+96.48%$55.2K-2.32%Stalk
Jun 2, 2026SellBBNXMark HopmanChief Commercial Officer5,329$12.61$770.5M-47.14%+96.48%$67.2K-3.91%Stalk
Jun 2, 2026SellBBNXStephen FeiderChief Financial Officer6,676$12.61$770.5M-47.14%+96.48%$84.2K-3.87%Stalk
Jun 2, 2026SellBBNXSean SaintPresident & CEO16,872$12.61$770.5M-47.14%+96.48%$212.7K-3.85%Stalk
Mar 4, 2026SellBBNXMark HopmanChief Commercial Officer353$11.57$770.5M-47.14%+96.48%$4.1K-0.25%10b5-1Stalk
Mar 2, 2026SellBBNXMark HopmanChief Commercial Officer834$12.36$770.5M-47.14%+96.48%$10.3K-0.42%Stalk
Mar 2, 2026SellBBNXSteven Jon RussellChief Medical Officer1,026$12.36$770.5M-47.14%+96.48%$12.7K-0.43%Stalk
Mar 2, 2026SellBBNXMike MensingerChief Product Officer1,064$12.36$770.5M-47.14%+96.48%$13.2K-0.43%Stalk
Mar 2, 2026SellBBNXStephen FeiderChief Financial Officer1,428$12.36$770.5M-47.14%+96.48%$17.7K-0.58%Stalk
Mar 2, 2026SellBBNXSean SaintPresident & CEO3,384$12.36$770.5M-47.14%+96.48%$41.8K-0.54%Stalk
Jan 6, 2026SellBBNXMike MensingerChief Product Officer2,200$30.10$770.5M-47.14%+96.48%$66.2K-2.65%10b5-1Stalk
Jan 2, 2026SellBBNXMike MensingerChief Product Officer7,800$29.61$770.5M-47.14%+96.48%$231.0K-4.47%10b5-1Stalk
Jan 2, 2026SellBBNXStephen FeiderChief Financial Officer40,000$17.32$770.5M-47.14%+96.48%$692.7K+0.00%10b5-1Stalk
Dec 2, 2025SellBBNXSteven Jon RussellChief Medical Officer1,025$29.34$770.5M-47.14%+96.48%$30.1K-0.57%Stalk
Dec 2, 2025SellBBNXMike MensingerChief Product Officer1,063$29.34$770.5M-47.14%+96.48%$31.2K-1.16%Stalk
Dec 2, 2025SellBBNXStephen FeiderChief Financial Officer1,427$29.34$770.5M-47.14%+96.48%$41.9K-3.24%Stalk
Dec 2, 2025SellBBNXMark HopmanChief Commercial Officer2,917$30.27$770.5M-47.14%+96.48%$88.3K-1.05%10b5-1Stalk
Dec 2, 2025SellBBNXSean SaintPresident & CEO3,278$29.34$770.5M-47.14%+96.48%$96.2K-3.24%Stalk
Oct 3, 2025SellBBNXStephen FeiderChief Financial Officer9,964$13.40$770.5M-47.14%+96.48%$133.5K+0.00%10b5-1Stalk
Oct 1, 2025SellBBNXStephen FeiderChief Financial Officer30,036$12.93$770.5M-47.14%+96.48%$388.4K+0.00%10b5-1Stalk
Sep 8, 2025SellBBNXStephen FeiderChief Financial Officer19,800$13.11$770.5M-47.14%+96.48%$259.6K+0.00%10b5-1Stalk
Sep 5, 2025SellBBNXStephen FeiderChief Financial Officer200$13.05$770.5M-47.14%+96.48%$2.6K+0.00%10b5-1Stalk
Sep 4, 2025SellBBNXMark HopmanChief Commercial Officer34,389$13.18$770.5M-47.14%+96.48%$453.3K-0.69%10b5-1Stalk
Sep 2, 2025SellBBNXMark HopmanChief Commercial Officer848$18.86$770.5M-47.14%+96.48%$16.0K-2.48%Stalk
Sep 2, 2025SellBBNXSteven Jon RussellChief Medical Officer1,015$18.86$770.5M-47.14%+96.48%$19.1K-1.41%Stalk
Sep 2, 2025SellBBNXMike MensingerChief Product Officer1,089$18.86$770.5M-47.14%+96.48%$20.5K-1.17%Stalk
Sep 2, 2025SellBBNXStephen FeiderChief Financial Officer1,462$18.86$770.5M-47.14%+96.48%$27.6K-3.21%Stalk
Sep 2, 2025SellBBNXSean SaintPresident & CEO3,359$18.86$770.5M-47.14%+96.48%$63.4K-3.21%Stalk
Aug 22, 2025SellBBNXStephen FeiderChief Financial Officer8,826$11.06$770.5M-47.14%+96.48%$97.6K+0.00%10b5-1Stalk
Aug 19, 2025SellBBNXStephen FeiderChief Financial Officer11,174$11.07$770.5M-47.14%+96.48%$123.7K+0.00%10b5-1Stalk
Aug 19, 2025SellBBNXMark HopmanChief Commercial Officer32,316$10.85$770.5M-47.14%+96.48%$350.8K+0.00%10b5-1Stalk
Jun 2, 2025SellBBNXMark HopmanChief Commercial Officer868$17.89$770.5M-47.14%+96.48%$15.5K-0.83%Stalk
Jun 2, 2025SellBBNXSteven Jon RussellChief Medical Officer1,039$17.89$770.5M-47.14%+96.48%$18.6K-0.48%Stalk
Jun 2, 2025SellBBNXMike MensingerChief Product Officer1,115$17.89$770.5M-47.14%+96.48%$19.9K-0.40%Stalk
Jun 2, 2025SellBBNXStephen FeiderChief Financial Officer1,497$17.89$770.5M-47.14%+96.48%$26.8K-1.08%Stalk
Jun 2, 2025SellBBNXSean SaintPresident & CEO3,439$17.89$770.5M-47.14%+96.48%$61.5K-1.07%Stalk
Jan 31, 2025BuyBBNXMike MensingerChief Product Officer43,938$12.91$770.5M-47.14%+96.48%$567.4K+10.36%Stalk